help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BORZONE, G.
Right arrow Articles by LISBOA, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BORZONE, G.
Right arrow Articles by LISBOA, C.

Am. J. Respir. Crit. Care Med., Volume 163, Number 7, June 2001, 1648-1653

Bleomycin-Induced Chronic Lung Damage Does Not Resemble Human Idiopathic Pulmonary Fibrosis

GISELLA BORZONE, RODRIGO MORENO, RODRIGO URREA, MANUEL MENESES, MANUEL OYARZÚN, and CARMEN LISBOA

Department of Respiratory Diseases and Medical Research Center, Pontificia Universidad Católica de Chile, and Program of Pathology, Institute of Biomedical Sciences, Universidad de Chile, Santiago, Chile

Administration of bleomycin into the lungs of experimental animals has been utilized as a model to understand human pulmonary fibrosis. Most of the studies, however, have focused on early stages of the lung reaction. We hypothesized that chronic stages of the model may not mimic idiopathic pulmonary fibrosis, since in preliminary studies, lung volume and compliance were not decreased. Eight male Sprague-Dawley rats receiving intratracheal bleomycin (0.5 U/100 g body weight) underwent measurement of FRC, inspiratory capacity, and lung compliance 120 d later. Lung histologic changes were evaluated using light microscopy. Eight rats without intervention served as controls. Results show that our model, in early stages, has histologic changes no different from those previously described elsewhere. In chronic stages, however, the model does not behave as a restrictive syndrome: FRC is normal or increased, whereas lung compliance is normal. Focal peribronchiolar inflammation and fibrosis associated with paracicatricial emphysematous changes are the main histologic features of long-term lung remodeling after bleomycin. We conclude that while the chronic stages of the model may be informative in understanding mechanisms of fibrosis, care should be taken not to extrapolate to human idiopathic pulmonary fibrosis. We speculate that the model might resemble a particular subgroup of human interstitial lung disease, namely, those involving peribronchiolar structures.




This article has been cited by other articles:


Home page
 ThoraxHome page
T J Williams and J W Wilson
Challenges in pulmonary fibrosis: 7 {middle dot} Novel therapies and lung transplantation
Thorax, March 1, 2008; 63(3): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Gauldie and M. Kolb
Animal models of pulmonary fibrosis: how far from effective reality?
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L151 - L151.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Borzone, L. Liberona, P. Olmos, C. Saez, M. Meneses, T. Reyes, R. Moreno, and C. Lisboa
Rat and hamster species differences in susceptibility to elastase-induced pulmonary emphysema relate to differences in elastase inhibitory capacity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1342 - R1349.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Vittal, H. Zhang, M. K. Han, B. B. Moore, J. C. Horowitz, and V. J. Thannickal
Effects of the Protein Kinase Inhibitor, Imatinib Mesylate, on Epithelial/Mesenchymal Phenotypes: Implications for Treatment of Fibrotic Diseases
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 35 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. V. Gonzalez, F. Le Bellego, and M. S. Ludwig
Imbalance of Receptor-Regulated and Inhibitory Smads in Lung Fibroblasts from Bleomycin-Exposed Rats
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 206 - 212.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
K Nakagome, M Dohi, K Okunishi, R Tanaka, J Miyazaki, and K Yamamoto
In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-{beta} in the lung
Thorax, October 1, 2006; 61(10): 886 - 894.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. M. Kelly, R. Leigh, S. E. Gilpin, E. Cheng, G. E. M. Martin, K. Radford, G. Cox, and J. Gauldie
Cell-specific Gene Expression in Patients with Usual Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 557 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Tsuchida, D. Engelberts, V. Peltekova, N. Hopkins, H. Frndova, P. Babyn, C. McKerlie, M. Post, P. McLoughlin, and B. P. Kavanagh
Atelectasis Causes Alveolar Injury in Nonatelectatic Lung Regions
Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 279 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. Chua and G. J. Laurent
Neutrophil elastase: mediator of extracellular matrix destruction and accumulation.
Proceedings of the ATS, July 1, 2006; 3(5): 424 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
C. Agostini and C. Gurrieri
Chemokine/Cytokine cocktail in idiopathic pulmonary fibrosis.
Proceedings of the ATS, January 1, 2006; 3(4): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
F. Chua, J. Gauldie, and G. J. Laurent
Pulmonary Fibrosis: Searching for Model Answers
Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 9 - 13.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Vittal, J. C. Horowitz, B. B. Moore, H. Zhang, F. J. Martinez, G. B. Toews, T. J. Standiford, and V. J. Thannickal
Modulation of Prosurvival Signaling in Fibroblasts by a Protein Kinase Inhibitor Protects against Fibrotic Tissue Injury
Am. J. Pathol., February 1, 2005; 166(2): 367 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. P. Cosgrove, K. K. Brown, W. P. Schiemann, A. E. Serls, J. E. Parr, M. W. Geraci, M. I. Schwarz, C. D. Cool, and G. S. Worthen
Pigment Epithelium-derived Factor in Idiopathic Pulmonary Fibrosis: A Role in Aberrant Angiogenesis
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 242 - 251.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Williams, D. Malarkey, L. Cohn, D. Patrick, J. Dye, and G. Toews
Identification of Spontaneous Feline Idiopathic Pulmonary Fibrosis: Morphology and Ultrastructural Evidence for a Type II Pneumocyte Defect
Chest, June 1, 2004; 125(6): 2278 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. S. Berman, D. Serlin, X. Li, G. Whitley, J. Hayes, D. C. Rishikof, D. A. Ricupero, L. Liaw, M. Goetschkes, and A. W. O'Regan
Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1311 - L1318.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Mata, A. Ruiz, M. Cerda, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo
Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats
Eur. Respir. J., December 1, 2003; 22(6): 900 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Koslowski, K. Knoch, E. Kuhlisch, D. Seidel, and M. Kasper
Cathepsins in bleomycin-induced lung injury in rat
Eur. Respir. J., September 1, 2003; 22(3): 427 - 435.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. Aoshiba, T. Tsuji, and A. Nagai
Bleomycin induces cellular senescence in alveolar epithelial cells
Eur. Respir. J., September 1, 2003; 22(3): 436 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Suzuki, K. Aoshiba, N. Yokohori, and A. Nagai
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Augments a Murine Model of Pulmonary Fibrosis
Cancer Res., August 15, 2003; 63(16): 5054 - 5059.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Bergeron, P. Soler, M. Kambouchner, P. Loiseau, B. Milleron, D. Valeyre, A.J. Hance, and A. Tazi
Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-{beta} and IL-10
Eur. Respir. J., July 1, 2003; 22(1): 69 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Suga, Y. Yuan, N. Ogasawara, T. Tsukuda, and N. Matsunaga
Altered Clearance of Gadolinium Diethylenetriaminepentaacetic Acid Aerosol from Bleomycin-injured Dog Lungs: Initial Observations
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1704 - 1710.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Duggan, C. L. McCaul, P. J. McNamara, D. Engelberts, C. Ackerley, and B. P. Kavanagh
Atelectasis Causes Vascular Leak and Lethal Right Ventricular Failure in Uninjured Rat Lungs
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1633 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
T. Betsuyaku, K. Kadomatsu, G. L. Griffin, T. Muramatsu, and R. M. Senior
Increased Basigin in Bleomycin-Induced Lung Injury
Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 600 - 606.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. J. Atkinson and R. M. Senior
Matrix Metalloproteinase-9 in Lung Remodeling
Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 12 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Ghosh, T. Mendoza, L. A. Ortiz, G. W. Hoyle, C. D. Fermin, A. R. Brody, M. Friedman, and G. F. Morris
Bleomycin Sensitivity of Mice Expressing Dominant-Negative p53 in the Lung Epithelium
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 890 - 897.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. C. Gabazza, O. Taguchi, Y. Adachi, E. C. Gabazza, O. Taguchi, and Y. Adachi
BLEOMYCIN-INDUCED LUNG FIBROSIS: THE AUTHORS SHOULD HAVE USED ANOTHER METHOD TO INDUCE PULMONARY LESIONS RESEMBLING HUMAN IDIOPATHIC PULMONARY FIBROSIS
Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 845b - 846.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Socioeconomic Issues in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 631 - 641.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. M. Day, Y. j. Suzuki, J. M. Lum, A. C. White, and B. L. Fanburg
Bleomycin upregulates expression of gamma -glutamylcysteine synthetase in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1349 - L1357.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society